Hu, G. and Root, M. Accuracy of prediction models in the context of disease management. Disease Management: 8:42-47 (2005).
Abstract
 

Building prediction models for coronary heart disease by synthesizing multiple longitudinal research findings. European Journal of Cardiovascular Prevention and Rehabilitation, 12:459-464 (2005).
Abstract

Combining information from multiple data sources to create multi-variable risk models: Illustration and preliminary assessment of a new method. Journal of Biomedicine & Biotechnology, 2:113-123 (2005).
Abstract

Dietary effects on non-traditional risk factors of heart disease. (a review) Nutrition Research 24:827-838 (2004).
Abstract

Prescribe by risk: The utility of a biomarker-based risk calculation in disease management to prevent heart disease. Disease Management, 8:106-113 (2005). Abstract

Hu, G. and Lesneski, E. The differences between claim-based health risk adjustment models and cost prediction models. Disease Management: 7:153-158 (2004).
Abstract

Assessing risk for coronary heart disease: Beyond Framingham. American Heart Journal 146:572-580 (2003).
(An editorial, no abstract)
 

The composite biomarker: a novel technology to predict statin disease prevention efficacy, longitudinal outcomes, and pharmacoeconomic impact.
VIEW PDF

Mortality Assessment Technology: a new tool for life insurance underwriting.
VIEW PDF

Comparisons of BioSignia’s Mortality Assessment Technology with life insurance company’s existing underwriting system in defining preferred class.
VIEW PDF

Synthesis analysis: Innovative biostatistics for drug development and human diagnostics.
VIEW PDF

Development of Diabetes Complication Progression Model
VIEW PDF